Finance

Lists
Why is CNTB down ၅.၃၈%?
Dive Deeper
CNTB:NASDAQ
Connect Biopharma Holdings Ltd
၀.၉၃ US$
-၅.၃၈%
(-၀.၀၅၃) 1D
၀.၉၀ US$
-၂.၇၅% (-၀.၀၂၆)
Pre-market
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTB...
Open
၀.၉၈ US$
High
၁.၀၈ US$
Low
၀.၈၉ US$
Mkt. cap
၅.၈၄ ကုဋေ
Avg. vol.
၇.၄၂ သန်း
Volume
၆.၆၀ သောင်း
52-wk high
၃.၈၂ US$
52-wk low
၀.၈၉ US$
EPS
-၁.၂၀ US$
Beta
-၀.၁၆
Shares outstanding
၆.၃၀ ကုဋေ
No. of employees
၆၄
Open
၀.၉၈ US$
High
၁.၀၈ US$
Low
၀.၈၉ US$
Mkt. cap
၅.၈၄ ကုဋေ
Avg. vol.
၇.၄၂ သန်း
Volume
၆.၆၀ သောင်း
52-wk high
၃.၈၂ US$
52-wk low
၀.၈၉ US$
EPS
-၁.၂၀ US$
Beta
-၀.၁၆
Shares outstanding
၆.၃၀ ကုဋေ
No. of employees
၆၄
News stories
From web sources and news partners
Yahoo! Finance Canada
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၁၈ နာရီ
CNTB Nov 2026 7.500 call (CNTB261120C00007500) Stock Price, News, Quote & History
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၂ ရက်
Connect Biopharma (NASDAQ:CNTB) Given Buy Rating at HC Wainwright
About Connect Biopharma Holdings Ltd
CEO-
Employees၆၄
Founded၂၀၁၂
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to CNTB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CNTB in the last 3 months.
Highest
Current ၀.၉၃ US$
၁၀.၀၀ US$ (+၉၇၈.၇၅%)
Average
၆.၈၆ US$ (+၆၄၀.၀၂%)
Lowest
၄.၀၀ US$ (+၃၃၁.၅၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
၇.၀၀ US$
+၆၅၅.၁%
10/02/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
၆.၀၀ US$
+၅၄၇.၂%
10/01/2026
Thomas Flaten
Lake Street
Buy
Maintained
၉.၀၀ US$
+၈၇၀.၉%
10/01/2026
Mazahir Alimohamed
Oppenheimer
Buy
Reiterated
၅.၀၀ US$
+၄၃၉.၄%
09/22/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
၄.၀၀ US$
+၃၃၁.၅%
09/17/2026
Julian Harrison
BTIG
Buy
Maintained
၁၀.၀၀ US$
+၉၇၈.၇%
08/27/2026
Biren Amin
Piper Sandler
Buy
Maintained
၇.၀၀ US$
+၆၅၅.၁%
08/13/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Initiated
၄.၀၀ US$
+၃၃၁.၅%
05/21/2026
Carl Byrnes
Northland Securities
Buy
Maintained
၇.၅၀ US$
+၇၀၉.၁%
04/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၆၀ သောင်း
-
၁.၆၉ သိန်း
၂.၇၇ သန်း
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၁၁ ကုဋေ
၁.၁၃ ကုဋေ
၁.၅၀ ကုဋေ
၁.၆၃ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆.၅၈ သန်း
၄.၂၄ သန်း
၄.၇၅ သန်း
၄.၁၀ သန်း
Operating expense
၁.၇၇ ကုဋေ
၁.၅၅ ကုဋေ
၁.၉၈ ကုဋေ
၂.၀၄ ကုဋေ
Total operating expenses
၁.၇၇ ကုဋေ
၁.၅၅ ကုဋေ
၁.၉၈ ကုဋေ
၂.၀၄ ကုဋေ
Operating income
-၁.၇၇ ကုဋေ
-၁.၅၅ ကုဋေ
-၁.၉၆ ကုဋေ
-၁.၇၆ ကုဋေ
Other non operating income
-၇.၀၀ ထောင်
၆.၀၀ သောင်း
-၃.၀၀ ထောင်
၆.၇၀ သောင်း
EBT including unusual items
-၁.၇၁ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၉၄ ကုဋေ
-၁.၇၂ ကုဋေ
EBT excluding unusual items
-၁.၇၁ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၉၄ ကုဋေ
-၁.၇၂ ကုဋေ
Income tax expense
၆.၁၀ သောင်း
၂.၇၀ သောင်း
၄.၈၀ သောင်း
၆.၀၀ သောင်း
Effective tax rate
-၀.၃၆%
-၀.၁၈%
-၀.၂၅%
-၀.၃၅%
Other operating expenses
-
-
-
-
Net income
-၁.၇၂ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၉၄ ကုဋေ
-၁.၇၃ ကုဋေ
Net profit margin
-၁၀၇,၅၀၀.၀၀%
-
-၁၁,၄၇၈.၁၁%
-၆၂၄.၄၂%
Earnings per share
-၀.၃၁
-၀.၂၇
-၀.၃၄
-၀.၂၇
Interest and investment income
၅.၄၅ သိန်း
၃.၈၄ သိန်း
၂.၆၀ သိန်း
၃.၁၃ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၅.၄၅ သိန်း
၃.၈၄ သိန်း
၂.၆၀ သိန်း
၃.၁၃ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၇၅ ကုဋေ
-၁.၅၃ ကုဋေ
-၁.၉၄ ကုဋေ
-၁.၇၄ ကုဋေ
Gain or loss from assets sale
-
၃.၀၀ ထောင်
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ